PTO gene patent hearing set for Nov. 29 and Dec. 7: issues include whether to patent, how to review.
PTO PUBLIC HEARINGS ON GENE SEQUENCE PATENT APPLICATIONS and the Human Genome Initiative will be held Nov. 29 at the University of California-San Diego and Dec. 7 in Arlington, Va. The Human Genome Initiative has raised the question of whether expressed nucleic acid sequences in the genome should be patentable. Policies must be established to "address these challenges," PTO said in a Nov. 14 Federal Register notice. Written comments should be directed to the Assistant Commissioner for Patents, Box DAC, Washington, D.C. 20231, marked to the attention of Esther Kepplinger, before Dec. 18.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth